U.S. FDA panel backs Puma Biotech`s breast cancer drug

Puma Biotechnology Inc’s experimental breast cancer drug reduces the risk of disease recurrence and should be approved, an advisory committee to the U.S. Food and Drug Administration concluded on Wednesday. More »